Time to market with the right product becomes a key in today’s vaccine market condition. Traditional 2D stacked vessels have been widely accepted as production platforms for vaccines, cell and gene therapies. Large scale vessels are bulky and require additional handling and incubator space. With proper considerations, these vessels can perform adequately, however, there is a need to increase product yields and improve process and operational efficiencies to meet evolving market demands.
Corning HYPER (High Yield PERformance) technology including HYPERFlask® and HYPERStack® cell culture vessels which brings an innovation to adherent cultures in conventional stacked vessels. In addition to improving operations, HYPER vessels can generate greater yields per volumetric footprint saving time, space, and labor.
In this webinar, learn more about Corning’s HYPER gas-permeable film technology and how this unique approach optimizes production value in the fields of vaccines and cell and gene therapy.